Does gender-specific BMI development modulate insulin sensitivity in extremely low birth weight infants?

Bettina C Gohlke1, Sonja Stutte, Peter Bartmann

  • 1Department of Pediatrics, University of Bonn, Bonn, Germany. bettina-gohlke@t-online.de

Insights

Extremely low birth weight (ELBW) children

Area of Science:

  • Pediatric Endocrinology
  • Neonatalogy
  • Metabolic Health

Background:

  • Survival rates for extremely low birth weight (ELBW) infants are increasing.
  • Understanding long-term metabolic outcomes in ELBW survivors is crucial.

Purpose of the Study:

  • To investigate the impact of birth weight, gender, and catch-up growth on metabolic parameters in ELBW children.
  • To identify early markers of metabolic health in this vulnerable population.

Main Methods:

  • A cohort of 63 ELBW children was assessed at a mean age of 5.8 years.
  • Growth parameters, including height and body mass index (BMI), were evaluated.
  • Metabolic markers such as insulin, glucose, IGF-I, and IGFBP-1/3 were measured.

Main Results:

  • Children who were small for gestational age (SGA) were shorter and had lower IGF-I and IGFBP-3 levels.
  • Catch-up growth was associated with lower IGFBP-1 concentrations.
  • Gender influenced weight development, with girls normalizing BMI earlier than boys, and girls exhibiting lower IGFBP-1 levels.

Conclusions:

  • Metabolic parameters in ELBW children are significantly influenced by catch-up growth and sex-specific weight trajectories.
  • These factors lead to measurable metabolic differences in early childhood.
  • Early identification of growth patterns can inform interventions for metabolic health in ELBW survivors.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...